Loading organizations...
§ Private Profile · Pessac, Aquitaine, France
AI company developing multimodal foundation models combining imaging, genomic, and clinical data for pharmaceutical companies, optimizing clinical.
Imagene AI, an Israeli company with a presence in the United States, develops multimodal foundation models that integrate imaging, genomic, and clinical data to advance precision medicine. Its platform analyzes complex patient biopsies and comprehensive data to optimize clinical trials and accelerate treatment matching for global pharmaceutical companies. The venture-backed firm has raised a total of $45 million in funding, including a $23 million Series B round, and employs approximately 30 individuals. Notable investors include Oracle founder Larry Ellison and Aguras Pathology Investments, supporting its mission to embed AI within drug development workflows. Imagene AI was founded in 2020 by Dean Bitan, Jonathan Zalach, and Shahar Porat. Its business model centers on venture-backed, embeds their AI platform within pharmaceutical companies to help optimize clinical trials.
Imagene has raised $21.5M across 1 funding round.
Imagene has raised $21.5M in total across 1 funding round.
Imagene has raised $21.5M across 1 funding round. Most recently, it raised $21.5M Seed / Series A in May 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 2, 2022 | $21.5M Series A | David Agus, Eyal Gura, Larry Ellison, Yodfat Harel Buchris | — | Announced |
Imagene has raised $21.5M in total across 1 funding round.
Imagene's investors include David Agus, Eyal Gura, Larry Ellison, Yodfat Harel Buchris.